Perrigo Co. (PRGO) is in the Pharma Industry

• Sort by
• View by Content Type
• View Related Content by Tag

• Best and Worst Performing Stocks of the Current Bear Market

  Hickey and Walters Bespoke submit: Since the current bear market began back on October 9th, 2007, the Russell 1,000 is down about 18%.  Of the stocks in the index, 8.5% are down more than 50%, while 25% are actually up since then.  Below we highlight the 25 best...

  External links 2008-08-25

  Tags: US Market, Financial, Arch Coal Inc., American International Group Inc., Alpha Natural Resources Inc., APP Pharmaceuticals Inc., Bucyrus International Inc., Boyd Gaming Corp., Avis Budget Group Inc., CF Industries Holdings Inc., CIT Group, Cleveland-Cliffs Inc., Continental Resources Inc., Encore Acquisition Co., E*Trade Financial Corp., Flowserve Corp., Fannie Mae, Freddie Mac, First Solar Inc., General Motors Corp., Hess Corp., Petrohawk Energy Corp., Helmerich & Payne Inc., Illumina Inc., Kansas City Southern, Lehman Brothers Holdings Inc., Las Vegas Sands Corp., MasterCard Inc., MBIA Inc., Massey Energy Co., Mosaic Co., MGIC Investment Corp., National City Corp., Office Depot Inc., Oshkosh Truck Corp., Perrigo Co., Rite Aid Corp., Regions Financial Corp., iStar Financial Inc., SLM Corp., SanDisk Corp., Sohu.com, Southwestern Energy Co., Tenet Healthcare Corp., Terra Industries Inc., Tesoro Corp., Wachovia Corp., Whiting Petroleum Corp., Walter Industries Inc., Washington Mutual Inc.

• Perrigo Picks Up On Profit

  John C. Lee submits: On August 18 before the market open, Perrigo PRGO announced Q4 earnings of $0.29 per share or $27.5 million vs. $0.20 per share or $18.8 million a year ago see conference call transcript. Excluding charges (impairment, improvement, restructuring, in-process R & D write off), PRGO reported...

  External links 2008-08-21

  Tags: Healthcare, Perrigo Co.

• Perrigo Co. F3Q08 (Qtr End 3/29/08) Earnings Call Transcript

  Perrigo Co. F3Q08 (Qtr End 3/29/08) Earnings Call Transcript

  Earnings calls 2008-05-06

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, Perrigo Co.

• Perrigo Co. F2Q08 (Qtr End 12/29/07) Earnings Call Transcript

  Perrigo Co. F2Q08 (Qtr End 12/29/07) Earnings Call Transcript

  Earnings calls 2008-02-06

  Tags: Perrigo Co., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

• Perrigo F1Q08 (Qtr End 9/29/07) Earnings Call Transcript

  Perrigo F1Q08 (Qtr End 9/29/07) Earnings Call Transcript

  Earnings calls 2007-11-01

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, Perrigo Co.

Additional Resources

• Perrigo Reports Record Sales, Earnings and Cash Flow from Operations for Fiscal 2008

  - Full year revenue increased $375 million, or 26 percent, to a record $1.8 billion, including $500 million for the fourth quarter - GAAP net income for the full year increased 84 percent to $135.8 million, or $1.43 per share - Adjusted net income for the...

  Articles 2008-08-18

• Perrigo Company to Present at the Bank of America Specialty Pharmaceuticals Conference

  ALLEGAN, Mich., Aug. 5 /PRNewswire-FirstCall/ -- Perrigo Company announced today that Joseph C. Papa, Perrigo's Chairman and CEO will present at the Bank of America Specialty Pharmaceuticals Conference on Thursday, August 7, at 11:00 a.m. ET at the Southampton Inn in Southampton, New York. The presentation will be...

  Articles 2008-08-05

• Perrigo Company Will Release Fiscal Year 2008 Results on August 18, 2008

  ALLEGAN, Mich., Aug. 5 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it will release financial results for its fiscal year 2008 on Monday, August 18, 2008 at approximately 8:00 a.m. ET. The Company will conduct a conference call at 10:00 a.m. ET hosted by Joseph C. Papa, Perrigo's...

  Articles 2008-08-05

• Perrigo to Grow in Michigan

  Company focused on producing quality, affordable healthcare ALLEGAN, Mich., July 15 /PRNewswire-FirstCall/ -- Perrigo Company , the world's largest manufacturer of over-the-counter healthcare products sold under the store-brand label, announced today its intent to invest $10.5 million to expand its facilities at its world headquarters in Allegan,...

  Articles 2008-07-15

• Smith and Nephew - appoints Non-Executive Director

  Smith & Nephew appoints Non-Executive Director10 July 2008Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technologybusiness, announces the appointment of an additional Non-ExecutiveDirector to the Board.Joseph C. Papa, aged 52, and based in Michigan is Chairman of PerrigoCompany. Perrigo is a leading global healthcare supplier that...

  Articles 2008-07-10

• Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference

  ALLEGAN, Mich., July 7 /PRNewswire-FirstCall/ -- Perrigo Company announced today that Joseph C. Papa, Perrigo's Chairman and CEO will present at the Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference on Tuesday, July 8, at 4:05 p.m. ET at the Four Seasons Hotel in Boston....

  Articles 2008-07-07

• High Growth Reported for the World Smoking Cessation Aids Market

  Reportlinker.com announces that a new market research report related to the Personal care industry is available in its catalogue. World Smoking Cessation Aids Market http://www.reportlinker.com/p090576/World-Smoking-Cessation-Aids-Market.html This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are...

  Articles 2008-07-02

• Perrigo Announces Approval for Rx Cetirizine Syrup

  ALLEGAN, Mich., June 19 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Syrup Rx only, 1mg/mL. The product is comparable to McNeil Consumer Healthcare's ZyrtecR Syrup, 1mg/mL, indicated...

  Articles 2008-06-19

• Perrigo Confirms Filing for Generic Version of VANOS®

  ALLEGAN, Mich., June 9 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it has filed an Abbreviated New Drug Application ANDA for Fluocinonide Cream 0.1%, a generic version of VANOSR Cream 0.1%. The Company believes that it is the first to file an ANDA with a Paragraph...

  Articles 2008-06-09

• Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008

  - Third quarter revenue increased $141 million, or 39 percent, to $504 million on important new product launches - GAAP net income increased 134 percent to $40 million, or $0.42 per share - Adjusted net income increased 100 percent to $44 million, or $0.47 per share...

  Articles 2008-05-06

• Extreme Fitness Brings on Producer to Showcase Products.

  M2 PRESSWIRE-13 March 2008-InvestSource Inc.: Extreme Fitness Brings on Producer to Showcase ProductsC1994-2008 M2 COMMUNICATIONS LTD RDATE:13032008 Stocks in the News: Extreme Fitness, Inc. (OTC: EXTF), Perrigo Company (NASDAQ: PRGO), Wyeth (NYSE: WYE), Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX),...

  Articles 2008-03-13

• Perrigo Company Receives Final Approval on Clobetasol Propionate Foam

  Court Issues Temporary Restraining Order ALLEGAN, Mich., March 11 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Clobetasol Propionate Foam, 0.05%. The product is...

  Articles 2008-03-11

• Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets

  ALLEGAN, Mich., Mar. 6 /PRNewswire-FirstCall/ -- Perrigo Company today announced that its partner, Teva Pharmaceutical Industries Ltd. , has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for over-the-counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets, 5 mg/120 mg. ...

  Articles 2008-03-06

• Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets

  ALLEGAN, Mich., March 4 /PRNewswire-FirstCall/ -- Perrigo Company today announced that it has begun shipping 20 mg Omeprazole delayed released tablets to its retail customers. This product delivers the same medicine at the same dose as Prilosec OTCR. Under terms of an agreement between Dexcel Pharma...

  Articles 2008-03-04

• Over-the-counter cetirizine hydrochloride tablets

  Perrigo Company recently reported that the FDA has granted final approval for the manufacturing and marketing of over-the-counter cetirizine hydrochloride tablets (5 mg and 10 mg). This product will be available under store brand labels, and is the generic equivalent of McNeil Consumer Healthcare's Zyrtec[R...

  Articles 2008-03-01